These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 392623)

  • 21. Letter: PGE2 as a vaginal abortifacient - diaphragm effect.
    Corson SL; Bolognese RJ
    Prostaglandins; 1975 Sep; 10(3):543-4. PubMed ID: 1197786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of labor using high-dose or low-dose prostaglandin vaginal pessaries.
    Hunter IW; Cato E; Ritchie JW
    Obstet Gynecol; 1984 Mar; 63(3):418-20. PubMed ID: 6366660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostaglandin E2 vaginal suppositories in pregnancy with an anencephalic fetus.
    Boehm FH; Killam AP; Chambers JF; Davidson KK
    Obstet Gynecol; 1980 Jun; 55(6):758-60. PubMed ID: 7383465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ripening of the uterine cervix and induction of labour at term with prostaglandin E2 in viscous gel.
    Wingerup L; Andersson KE; Ulmsten U
    Acta Obstet Gynecol Scand; 1978; 57(5):403-6. PubMed ID: 364917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of extrauterine fetal death with failure of prostaglandin E2 suppositories.
    Orr JW; Huddleston JF; Goldenberg RL; Knox GE; Davis RO
    Obstet Gynecol; 1979 Mar; 53(3 Suppl):56S-58S. PubMed ID: 424129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of labour with vaginal prostaglandin E2 pessaries.
    Hefni MA; Lewis GA
    Br J Obstet Gynaecol; 1980 Mar; 87(3):199-202. PubMed ID: 7387921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mid-trimester abortion induced by intravaginal administration of prostaglandin E2 suppositories.
    Lauersen NH; Secher NJ; Wilson KH
    Am J Obstet Gynecol; 1975 Aug; 122(8):947-54. PubMed ID: 1155530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitation of uterine activity after vaginal administration of prostaglandins.
    Henzl MR; Arvealo TN; Noriega L; Aznar R; Ortega E; Segre E
    Adv Biosci; 1973; 9():767-72. PubMed ID: 4805889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of pre-induction vaginal prostaglandin E2 gel upon subsequent labour.
    Mackenzie IZ; Embrey MP
    Br J Obstet Gynaecol; 1978 Sep; 85(9):657-61. PubMed ID: 698144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Midtrimester pregnancy termination with prostaglandin E2 vaginal suppositories.
    Hochman M; Laufe LE
    J Reprod Med; 1976 May; 16(5):263-8. PubMed ID: 933105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostaglandin E2 induction of labor for fetal demise.
    Kent DR; Goldstein AI
    Obstet Gynecol; 1976 Oct; 48(4):475-8. PubMed ID: 967387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and efficacy of vaginal prostaglandin E2 suppositories in the management of third-trimester fetal demise.
    Kent DR; Goldstein AI; Linzey EM
    J Reprod Med; 1984 Feb; 29(2):101-2. PubMed ID: 6584630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uterine priming with oral prostaglandin E2 prior to elective induction with oxytocin.
    Golbus MS; Creasy RK
    Prostaglandins; 1977 Sep; 14(3):577-81. PubMed ID: 333516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dramatic pyrexic and cardiovascular response to intravaginal prostaglandin E2.
    Phelan JP; Meguiar RV; Matey D; Newman C
    Am J Obstet Gynecol; 1978 Sep; 132(1):28-32. PubMed ID: 696780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early midtrimester pregnancy termination. A comparison of dilatation and evacuation and intravaginal prostaglandin E2.
    Robins J; Surrago EJ
    J Reprod Med; 1982 Jul; 27(7):415-9. PubMed ID: 6956734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Preparation of the uterine cervix before induction of labor using the prostaglandin E2 (PGE2) vaginal tablet].
    Lomícková T; Mandys F; Kovarík J
    Cesk Gynekol; 1987 Feb; 52(1):18-24. PubMed ID: 3552266
    [No Abstract]   [Full Text] [Related]  

  • 37. Induction of labor with PGE2 vagina suppositories.
    Fuselier PG; Wittcoff H
    J La State Med Soc; 1977 Jul; 129(7):175-7. PubMed ID: 908861
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of two prostaglandins used to terminate midtrimester pregnancy.
    Gookin KS; White CK; Whitworth NS; Wiser WL; Morrison JC
    South Med J; 1984 Jun; 77(6):717-8, 721. PubMed ID: 6587588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostaglandin vaginal suppositories: a simple and safe approach to the induction of labor.
    Shepherd JH; Bennett MJ; Laurence D; Moore F; Sims CD
    Obstet Gynecol; 1981 Nov; 58(5):596-600. PubMed ID: 6946350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Labor induction with 3 mg of prostaglandin E2 vaginal tablets. A renaissance of programmed labor? Results of a prospective randomized study].
    Husslein P; Egarter C; Sevelda P; Genger H; Salzer H; Kofler E
    Geburtshilfe Frauenheilkd; 1986 Feb; 46(2):83-7. PubMed ID: 3514366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.